We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Dipeptidyl-Peptidase-4 and Glucagon-like-Peptide-1, a Link in the Connection between Periodontitis and Diabetes Mellitus—What Do We Know So Far?—A Scoping Review.
- Authors
Gheonea, Theodora Claudia; Șurlin, Petra; Nicolae, Flavia Mirela; Gheorghe, Dorin Nicolae; Popescu, Dora Maria; Rogoveanu, Ion
- Abstract
Periodontitis is a common condition affecting the tissues surrounding and supporting teeth. In addition to oral health concerns, periodontal disease increases the chance of developing systemic illnesses including type 2 diabetes mellitus. Porphyromonas gingivalis, a key-stone pathogen that has been linked to the pathophysiology of periodontal disease, can generate a series of dipeptide producing exopeptidases, dipeptidyl peptidases (DPP). DPP-4 levels in gingival crevicular fluid have been shown to increase during active periodontal disease, which may lead to their association with the disease's progression. Following oral glucose administration, mice injected with DPP-4 had higher blood glucose than the control group. DPP-4 inhibitors are used to treat patients with type 2 diabetes mellitus in order to extend the half-life of incretins. Elevated glucagon-like peptide-1 (GLP-1) levels following periodontal therapy could be considered new and applicable real-world evidence confirming the experimental findings of a beneficial interaction between oral microbiota and incretin axis. GLP-1 receptor agonist exendin-4 enhanced the osteoblast proliferation and development of these stem cells and inhibited the effects of glucose on the cells. In addition to lowering blood sugar, liraglutide, a GLP-1 receptor agonist, also possesses anti-inflammatory and bone-protective properties. These findings support the use of GLP-1 in the management and prevention of diabetic periodontitis.
- Subjects
DIABETES; TYPE 2 diabetes; PERIODONTITIS; GASTRIC inhibitory polypeptide; GLUCAGON-like peptide-1 agonists; ORAL drug administration; PERIODONTAL disease
- Publication
Journal of Clinical Medicine, 2024, Vol 13, Issue 3, p903
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm13030903